GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness
Open accessThe DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Abstract
Glycogen synthase kinase 3β (GSK3β), originally described as a negative regulator of glycogen synthesis, is a molecular hub linking numerous signaling pathways in a cell. Specific GSK3β inhibitors have anti-depressant effects and reduce depressive-like behavior in animal models of depression. Therefore, GSK3β is suggested to be engaged in the pathogenesis of major depressive disorder, and to be a target and/or modifier of anti-depressants’ action. In this review, we discuss abnormalities in the activity of GSK3β and its upstream regulators in different brain regions during depressive episodes. Additionally, putative role(s) of GSK3β in the pathogenesis of depression and the influence of anti-depressants on GSK3β activity are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment with GSK-3β inhibitors reduces the production of QUIN and subsequently alleviates depressive, anxious, and aggressive behaviors in animal models (137).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [137]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, post-mortem studies have reported elevated GSK-3β mRNA levels in the hippocampus of patients with major depression.”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [137]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 1×
“Systemic injection of pro-inflammatory cytokines induces depression-like phenotype [132].”
BackgroundWnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583 · cited 1×
“β-catenin, a multifunctional protein downstream to WNT signaling [112], is another factor putatively regulating stress resilience development [113].”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 1×
“Both of these pathways reduce the activity of GSK3β, but only PI3K/AKT acts through phosphorylation of Ser9 [92,93].”
BackgroundMalhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492 · cited 1×
“These findings resulted in the monoaminergic hypothesis of the MDD pathogenesis, which assumes that MDD is caused by a reduction in noradrenaline (NA) and serotonin (5-HT) neurotransmission [4].”
BackgroundSubgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · cited 1×
“In 1997, a reduction in the cortical volume of patients suffering from different types of depression was linked to decreased brain activity [74].”
BackgroundGut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460 · cited 1×
“It is worth noting that multiple research groups have reported that the manipulation of the gastrointestinal tract microbiome status affects anxiety- and depressive-like behaviors in rodents, and that the administration of probiotics reduces such behaviors [151].”
BackgroundKrishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 1×
“It corresponds to results of post mortem studies of human brains where an increased level of BDNF in nucleus accumbens has been detected [90].”
ResultA molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 2×
“The discovery that GSK3β is a direct target of lithium action [63] has raised the possibility that lithium exerts its effects through the odulating activity of the kinase.”
Background
Cited by
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
Molecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504
“Polyamines such as spermidine, spermine, putrescine and agmatine are short, aliphatic amines that impact several pathways and synaptic activity by a variety of mechanisms; the impacted molecules and pathways include almost all systems mentioned in this review, e.g., Na+-, K+- and Ca2+-channels, 5-HT, NMDA, AMPA, kaina…”
BackgroundXiao, Z., Cao, Z., Yang, J., Jia, Z., Du, Y., Sun, G., Lu, Y. F., & Pei, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114594 · Cited by 76
Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases
Marosi, M., Arman, P., Aceto, G., D’Ascenzo, M., & Laezza, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084413 · Cited by 46
“Herein, we provide an overview of the mechanisms by which GSK3β mediates direct and indirect effects on Nav and Kv channels with implications for neuronal excitability, plasticity, and ultimately vulnerability to neuropsychiatric disorders [34,53,56,58,59].”
BackgroundUrkon, M., Ferencz, E., Szász, J. A., Szabó, M. I. M., Orbán-Kis, K., Szatmári, S., & Nagy, E. E. (2025) · Pharmaceuticals · doi:10.3390/ph18050614 · Cited by 44
“In addition, enhanced BDNF signaling or TNF α reduction could also contribute to Akt/GSK-3 β regulation [185].”
Metadata
- Authors
- Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A.
- Affiliations
- University of Wrocław (PL)
- Corresponding author
- Duda, Przemysław
- Gizak, Agnieszka
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-03-16
- Volume
- 9
- Issue
- 3
- Pages
- 727
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7140610
- OpenAlex
- W3012493302
- Cited by
- 84
- References
- 211
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 11 · 2023: 12 · 2022: 12 · 2021: 11 · 2020: 3
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Polish Ministry of Science and Higher Education (UMO-2015/19/B/NZ1/00332)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- GSK3β, glycogen synthase kinase-3β, major depressive disorder, depression pathogenesis, antidepressant response, GSK-3β inhibitors, antidepressant mechanism, upstream regulators, brain regions, depression-like behavior
- MeSH terms
- Neuroprotection, Glycogen Synthase Kinase 3 beta, Animals, Brain, Major Depressive Disorder, Hippocampus, Humans, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness. https://app.cochat.ai/papers/10.3390/cells9030727
- The paper
- Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A. (2020). GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness. Cells. https://doi.org/10.3390/cells9030727
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.